1Seidl C,Korbitzer J,Badenhoop K,et al.Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients.Hum Immunol,2001,62:523-529.
2Vos K,van der Horst-Bruinsma IE,Hazes JM,et al.Evidence for a protective role of the human leukocyte antigen class Ⅱ region in early rheumatoid arthritis.Rheumatology,2001,40:133-139.
4Turesson C,Englund P,Jacobsson LTH,et al.Increased endothelial expression of HLA-DQ and interleukin 1 in extra-articular rheumatoid arthritis:results from immunohistochemical studies of skeletal muscle.Rheumatology,2001,40:1346-1354.
5Fugger L,Svejgaard A.The HLA-DQ7 and-DQ8 association in DR4-positive rheumatoid arthritis patients.Tissue Antigens,1997,50:494-500.
6Seidl C,Donner H,Petershofen E,et al.An endogenous retroviral long terminal repeat at the HLA-DQB1 gene locus confers susceptibility to rheumatoid arthritis.Hum Immunol,1999,60:63-68.
7Zanelli E,Huizinga TW,Guerne PA,et al.An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition.Immunogenetics,1998,48:394-401.
8Laivoranta-Nyman S,Mottonen T,Hermann R,et al.HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.Ann Rheum Dis,2004,63:1406-1412.
3McCuskey CT, Reid B, Green D, et al. HLA-D region antigens in patients with rheumatoid arthritis[J]. Arthritis Rheum,1991,34:192
4Zanelli E, Huizinga TW, Guerne PA, et al. An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition[J]. Immunogenetics, 1998 , 48:394
5Wallin J, Carlsson B, Strom H, et al. A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis[J]. Arthritis Rheum , 1988,31:72
6Arnett FC, Edworth S, Blook DA, et al. The 1987 revised ARA criteria for rheumatoid arthritis[J]. Arthritis Rheum,1987,30:17
7Siegert CEH, Vleming LJ, Vandenbrouche JP, et al. Measurement of disability in Dutch rheumatoid arthritis patients[J]. Clin Rheumatol,1984,3:305
8Jarvinen P, Aho K. Twin studies in rheumatic diseases[J]. Seminar arthritis,1994,24:29
9Stastny P. Association of B-cell alloantigen DRw4 with rheumatoid arthritis[J]. N Engl J Med,1978,298:869
10Yuan Guohua, Shi Guiying. Using PCR for HLA-DR1 and DR4 typing in patients with rheumatoid arthritis[J]. Rheum,1995,35:325
2Niewold TB, Harrison M J, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis[J]. QJM, 2007,100(4) : 193-201.
3Dubrous P,Gardet V, Hugard L. Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid {actor for rheumatoid arthritis diagnosis [ J ]. Pathol Biol ( Paris ), 2005, 53 (2) :63-67.
4Zhu T, Feng L. Comparison of anti mutated citrullinated vimen tin, anti-cyclic citrullinated peptides, anti glucose-6 phosphate isomerase and anti-keratin antihodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients. [J]. Int J Rheum Dis,2013,16(2) :157-161.
5Shi J, van de Stadt IrA, Levarht EW, et al. Anti carbamylated pro tein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis[J]. Arthritis Rheum, 2013, 65(4) :911-915.
6Debaugnies F, Servais G, Badot V, et al. Anti cyclic citrullinated peptide antibodies:a comparison of different assays for the diag nosis of rheumatoid arthritis [J]. Scand J Rheumatol, 2013, 42 (2) :108-114.
7I.i QZ,Karp DR,Quan J,et al. Risk factors for ANA positivity in healthy persons[J]. Arthritis Res Ther,2011,13(2) :R38.
8Pasquet F, Pavic M, Ninet J, et al. Autoimmune diseases and cancers. First part: Cancers complicating autoimmune diseases and their treatment[J]. Rev Med Interne, 2014,35(5):310-316.
9Keen HI,Emery P.How should we manage early rheumatoid arthritis? From imaging to intervention[J]. Curr Opin Rheumatol, 2005,17(3):280-285.
10Tugnet N,Cooper SC,Douglas KM. Methotrexate therapy,rheumatoid arthritis,and life-threatening liver complications: should we be monitoring more closely?[J]. Scand J Rheumatol,2012,41(2):163-164.
